APOD and atherosclerosis: Furthermore, a prior separate FHS investigation found that protein level of APOD is also decreased in MI new-onset patients compared to controls [36], providing orthogonal evidence for APOD as an attractive novel candidate for clinical and subclinical atherosclerosis.